An earlier proposed endoperoxide intermediate in the biosynthesis of prostaglandins was detected in short-time incubations of arachidonic acid with the microsomal fraction of homogenates of sheep vesicular glands. Conversion of the endoperoxide into prostaglandin E2 was stimulated by reduced glutathione but suppressed by p-mercuribenzoate and N-ethylmaleimide. The methyl ester of an unknown compound was isolated by solvent extraction and thin-layer chromatography after short-time incubation of arachidonic acid with the microsomal fraction and p-mercuribenzoate. This derivative was identical to the methylester of the endoperoxide, as shown by its conversion into the methyl esters of li-dehydroprostaglandin F2u and prostaglandin E2 by spontaneous rearrangement and its conversion into the methyl ester of prostaglandin F2,r by mild chemical reduction. The smooth muscle-stimulating activity of the endoperoxide ester on the isolated rabbit aortas trip was 4-to 8-times higher than that of the methyl ester of prostaglandin E2.
glandin (PG) biosynthesis was first proposed in 1965 (1). When PGEI was biosynthesized from 8,11,14-eicosatrienoic acid in an atmosphere of 1602/1802, the two oxygen functions of the five-membered ring contained either two atoms of 160 or two atoms of 180, but not one atom of 160 and one of 180. This result showed that the oxygens of the keto and hydroxyl groups at C-9 and C-11, respectively, originated in the same oxygen molecule and indicated the formation of a cyclic peroxide derivative that could be isomerized into a 1,3-hydroxy ketone (PGE compounds) or reduced into a 1,3-diol (PGF, compounds) . Further studies on the mechanism of the transformation (for review, see ref.
2) showed that the initial step consisted of a lipoxygenase-like reaction in which the pro-S hydrogen at C-13 was removed, the Al double bond was isomerized into the A12 position, and oxygen was inserted at C-11. The subsequent steps leading to the endoperoxide were visualized to consist of attack by oxygen at C-15, shift of the A12 double bond, and formation of a new bond between C-8 and C-12. In additional studies, 12-hydroxy-8, 10-heptadecadienoic acid and malonaldehyde were identified as by-products in the conversion of 8,11,14-eicosatrienoic acid into PGE1 by microsomes from the vesicular gland of sheep (3--5) . The formation of these compounds was visualized to occur by fragmentation of the endoperoxide.
The simultaneous formation of PGFina (6, 4) , 1 1-dehydroPGFlcx (6, 4, 7) , and PGE1 also supported the existence of an endoperoxide derivative.
In the present l)aper, we PGF2 species, i.e., unlabeled PGF2a and PGF2,9 and deuteriumlabeled PGF2< and PGF2s, derived from the incubation product (see Fig. 1 ). PGF2a and 11-dehydro-PGF2a (Fig. 3B ). p-Mercuribenzoate decreased the rate of formation of PGE2 but enhanced the peak of PGF2a (Fig. 3C ).
Isolation of Endoperoxide Derivative. Thin-layer radiochromatographic analysis of material recovered after incubation of [1-14C]arachidonic acid for 30 sec in the presence of 1 mM p-mercuribenzoate showed the presence of a radioactive derivative (Compound X, RF = 0.49 in solvent system A) that was slightly less polar than the methyl ester of PGB2 (RF = 0.40) but more polar than the monohydroxy esters (RF = 0.73-77) (Fig. 4A) . The unknown derivative that accounted for 10-20% of the radioactivity applied on the TLC plate gave a positive reaction with the ferrous thiocyanate peroxide reagent (see ref. 12) , indicating that it contained a peroxide or hydroperoxide group. The derivative was formed in about the same yield in incubations performed in the presence of 1 mrM N-ethylmaleimide but in much lower yield when sulfhydryl group reagents were omitted. Furthermore, the derivative was not present when the incubation mixture was treated with SnCl2 in ethanol (Fig. 4B ). In this case the peak near the origin increased. This material ( chromatography. Two peaks with retention times corresponding to C-24.0 and C-24.5 appeared (reference, MOMe3Si derivative of the methyl ester of PGE2, C-24.0, and C-24.5). The mass spectra recorded on the major peaks of the two samples (C-24.5) were identical, conclusively showing that Compound I was identical to the methyl ester of PGE2.
Compound II, which showed a chromatographic behavior similar to that expected for the methyl esters of 1 1-dehydroPGFia (7) and 11-dehydro-PGF2a*, was converted into the IVMe3Si derivative and analyzed by gas-liquid radiochromatography. A peak of mass and radioactivity with a retention time equivalent to C-24. The above data show that Compound X underwent a rearrangement that afforded the methyl esters of 11-dehydroPGF2a (major isomer) and PGE2. It appeared that this rearrangement occurred when the derivative was adsorbed to the silica gel of the TLC plate in the absence of solvent, since when the derivative was recovered from the silica gel immediately after development and rechromatographed no formation of keto-prostaglandins could be detected. ethanol-Bucher medium (5: 1, v/v). The material in the zone corresponding to the peroxide derivative (RF = 0.49) was rechromatographed (solvent system A) and found to contain 40-70% of a polar derivative that cochromatographed with the methyl ester of PGF2a (RF = 0.03; RF = 0.35 in solvent system B). On gas-liquid radiochromatographic analysis of the Me3Si derivative, a peak of mass and radioactivity with a retention time corresponding to C-24.1 appeared (reference, Me3Si derivative of the methyl ester of PGF2a, C-24.1). The mass spectra recorded on the Me3Si derivatives of the unknown and of the reference were identical. These data conclusively showed that the methyl ester of PGF2a was the main product formed on SnCl2 reduction of Compound X.
Smooth Muscle-Stimulating Activity of Compound X. The zone of the TLC plate corresponding to the peroxide derivative (see Fig. 4A ) was scraped off immediately after development and eluted with diethyl ether. After filtration and evaporation a solution of Compound X in acetone was prepared (49 ng/,ul, stored at -70°). This material was tested on the isolated rabbit aorta strip (see ref. 13 ) with the methyl ester of PGE2 as reference. The smooth muscle-stimulating activity was 4-to 8-times higher than that of the methyl ester of PGE2 (Fig. 5) . Thin-layer radiochromatographic analysis of the material remaining after the biological testing showed a major peak with RF = 0.49 (Compound X) and a smaller peak with RF = 0.60. No peaks at the positions of the methyl esters of 11-dehydro-PGF2a, PGE2, or PGF2i, were present.
DISCUSSION
The aim of the present investigation was to detect and, if possible, isolate the postulated endoperoxide. In the first part of the study short-time incubations of [-14C ]arachidonic acid with sheep vesicular gland microsomes were performed. The incubation mixtures were treated with stannous chloride in ethanol in order to reduce endoperoxide into PGF2a (see Fig. 1 ). In one set of experiments, sodium hydroxide was subsequently added in order to convert PGE2 into PGB2, the methyl ester of which was determined by thin-layer radiochromatography. It was found that the rate of formation of PGE2 was significantly slower than the rate of formation of oxygenated products (Fig. 2) . In another set of experiments sodium borodeuteride reduction was performed after treatment with SnC12. The resulting PGF2 species (Fig. 1) were determined by multiple-ion analysis. In this way it was possible to assay PGE2 as well as 11-dehydro-PGF2a and PGF2a. These experiments confirmed the rate differences mentioned above and demonstrated the formation of 4-12% of 1 1-dehydro-PGF2. (Fig. 3A) . Most significant, however, was the finding of a peak of PGF2a in the initial phase of the incubation period (Fig. 3A) . No metabolic transformation of PGF compounds has been observed in preparations of sheep vesicular gland (6, 4) , and it was thus unlikely that the PGF2, peak could be ascribed to enzymatic formation of PGF2a followed by rapid metabolic degradation. Also, when the SnCl2 and sodium borodeuteride reduction was omitted the peak of PGF2a disappeared, indicating that PGF2a was formed by chemical reduction of an oxygenated derivative present in the initial phase of the incubation. That an oxygenated intermediate was formed and temporarily accumulated was also suggested by the finding that the rate of formation of PGE2 was slower than the rate of oxygenation of the precursor acid.
Further support for the existence of an oxygenated intermediate that was convertible into PGF2a by SnCl2 reduction came from experiments in which reduced glutathione and p-mercuribenzoate were added to the microsomal suspension. The former agent increased the rate of PGE2 formation (see ref. 4 ) and suppressed the peak of PGF2a (Fig. 3B) , whereas the latter agent decreased the rate of PGE2 formation with simultaneous increase in height and duration of the PGF2a peak (Fig. 3C) .
The latter part of the work was concerned with isolation of the oxygenated intermediate detected by the above experiments. On thin-layer radiochromatographic analysis of the product (methyl esters) isolated after incubation for 30 sec of [1-'4C]arachidonic acid with microsomes in the presence of 1 mM p-mercuribenzoate, a radioactive derivative with RF=0.49 (Compound X) appeared (Fig. 4) . The identity of this derivative with the methyl ester of the earlier postulated endoperoxide was based on (a) its positive test with a peroxide reagent; (b) its mobility on TLC that was between that of a monohydroxy fatty acid methyl ester and the methyl ester of PGB2 (monohydroxy-monoketo ester); (c) its conversion into the methyl ester of PGF2a by SnCl2 in ethanol; and (d) its spontaneous rearrangement on the TLC plate into a mixture of the methyl esters of 11-dehydro-PGF2a (major isomer) and PGE2. The last-mentioned finding proved that The release of a rabbit aorta contracting substance from guinea pig lung was described by Piper and Vane (13) . Indomethacin, an inhibitor of prostaglandin biosynthesis (14) , blocked the formation of the rabbit aorta contracting substance (15) , and it was suggested that this substance might be identical to an intermediate in prostaglandin biosynthesis (15) . The present work demonstrates that the endoperoxide intermediate has strong stimulating activity on the rabbit aorta strip (Fig. 5) . However, it remains to be demonstrated whether this compound is identical to the rabbit aorta contracting substance.
The results of the present work suggest that biosynthesis of prostaglandins occurs in a stepwise way with several enzymes and not by a concerted reaction on a single enzyme (Fig. 6) . We propose the existence of an endoperoxide isomerase that catalyzes rearrangement of the endoperoxide intermediate into PGE compounds and an endoperoxide reductase that catalyzes reduction of the endoperoxide into PGF,, compounds (Fig. 6) . The increased accumulation of endoperoxide brought about by p-mercuribenzoate and N-ethylmaleimide (Fig. 3C) is probably explained by inhibition of the isomerase enzyme. The previously observed selective inhibition of formation of PGE compounds in the presence of a bicyclo [2.2.1 ]heptene derivative, a structural analog of the endoperoxide (16) , is probably also due to inhibition of the endoperoxide isomerase.
The recognition of the endoperoxide as an intermediate in prostaglandin biosynthesis together with the presented methods for studying its formation and transformation seem to open new possibilities for isolation and studies of the component enzymes.
